{"id":28305,"date":"2026-02-07T11:19:01","date_gmt":"2026-02-07T11:19:01","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/global-leukemia-therapeutics-market-industry-mordor\/"},"modified":"2026-09-18T10:13:48","modified_gmt":"2026-09-18T01:13:48","slug":"global-leukemia-therapeutics-market-industry-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/global-leukemia-therapeutics-market-industry-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \ubc31\ud608\ubcd1 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/global-leukemia-therapeutics-market-industry_1660740066619_Logo-LTM.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/global-leukemia-therapeutics-market-industry-size-image-1767808870181.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc99d\uac00\ud558\ub294 \ubc31\ud608\ubcd1 \ubd80\ub2f4<\/li>\n<li class=\"toc-level-3\">4.2.2 \ud45c\uc801 \ubc0f \uba74\uc5ed \uce58\ub8cc\ubc95\uc758 \ubc1c\uc804<\/li>\n<li class=\"toc-level-3\">4.2.3 \ud5a5\uc0c1\ub41c \uc870\uae30 \uc9c4\ub2e8 \ubc0f \ud658\uc790 \uc778\uc2dd<\/li>\n<li class=\"toc-level-3\">4.2.4 \uc804\ub7b5\uc801 \ud611\ub825 \ubc0f R&amp;D \ud22c\uc790<\/li>\n<li class=\"toc-level-3\">4.2.5 \ubcd1\uc6a9 \uc694\ubc95 \ucc44\ud0dd<\/li>\n<li class=\"toc-level-3\">4.2.6 AI \uae30\ubc18 \uc57d\ubb3c \uc7ac\ucc3d\ucd9c\uc774 \ud30c\uc774\ud504\ub77c\uc778 \uac00\uc18d\ud654<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc2e0\uaddc \uce58\ub8cc\uc81c\uc758 \ub192\uc740 \ube44\uc6a9<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc5c4\uaca9\ud55c \uaddc\uc81c \ubc0f \uc0c1\ud658 \uc7a5\ubcbd<\/li>\n<li class=\"toc-level-3\">4.3.3 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \ubc0f \uc138\ud3ec \uce58\ub8cc\uc81c \uc81c\uc870 \ubcd1\ubaa9 \ud604\uc0c1<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc800\uc18c\ub4dd \ubc0f \uc911\uac04 \uc18c\ub4dd \uad6d\uac00(LMICs)\uc5d0\uc11c \ucf5c\ub4dc\uccb4\uc778 \ubb3c\ub958\ub85c \uc778\ud55c \uc811\uadfc \uc81c\ud55c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uac00\uce58 \/ \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uacf5\uae09\uc5c5\uccb4\uc758 \ud611\uc0c1\ub825<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\uc758 \ud611\uc0c1\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58-USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uce58\ub8cc \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \ud654\ud559\uc694\ubc95<\/li>\n<li class=\"toc-level-3\">5.1.2 \uba74\uc5ed\uc694\ubc95<\/li>\n<li class=\"toc-level-3\">5.1.3 \ud45c\uc801 \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.1.4 CAR-T \uc138\ud3ec \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.1.5 \uc720\uc804\uc790 \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.1.6 \uc904\uae30\uc138\ud3ec \uc774\uc2dd<\/li>\n<li class=\"toc-level-3\">5.1.7 \uae30\ud0c0 \uce58\ub8cc \uc720\ud615<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \ubc31\ud608\ubcd1 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uae09\uc131 \ub9bc\ud504\ubaa8\uad6c \ubc31\ud608\ubcd1<\/li>\n<li class=\"toc-level-3\">5.2.2 \uae09\uc131 \uace8\uc218\uc131 \ubc31\ud608\ubcd1<\/li>\n<li class=\"toc-level-3\">5.2.3 \ub9cc\uc131 \ub9bc\ud504\uad6c\uc131 \ubc31\ud608\ubcd1<\/li>\n<li class=\"toc-level-3\">5.2.4 \ub9cc\uc131 \uace8\uc218\uc131 \ubc31\ud608\ubcd1<\/li>\n<li class=\"toc-level-3\">5.2.5 \uae30\ud0c0 \ubc31\ud608\ubcd1 \uc720\ud615<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uce58\ub8cc \uc591\uc2dd\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uc800\ubd84\uc790 \uc57d\ubb3c<\/li>\n<li class=\"toc-level-3\">5.3.2 \ub2e8\uc77c\ud074\ub860 \ud56d\uccb4<\/li>\n<li class=\"toc-level-3\">5.3.3 CAR-T \uc138\ud3ec \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.3.4 \uc720\uc804\uc790 \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.3.5 \uc774\uc911\ud2b9\uc774\uc131 \ud56d\uccb4<\/li>\n<li class=\"toc-level-3\">5.3.6 RNA \uae30\ubc18 \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.3.7 \uae30\ud0c0 \uc591\uc2dd<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ud22c\uc5ec \uacbd\ub85c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \uacbd\uad6c<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc815\ub9e5<\/li>\n<li class=\"toc-level-3\">5.4.3 \ud53c\ud558<\/li>\n<li class=\"toc-level-3\">5.4.4 \uae30\ud0c0 \uacbd\ub85c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc5f0\ub839 \uadf8\ub8f9\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \uc18c\uc544 (<14\uc138)<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc131\uc778 (15\u201364\uc138)<\/li>\n<li class=\"toc-level-3\">5.5.3 \ub178\uc778 (65\uc138 \uc774\uc0c1)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.6 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.6.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.6.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.6.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.6.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.6.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.6.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.6.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.6.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.6.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.6.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.6.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.6.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.6.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.6.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.6.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.6.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.6.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.6.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.6.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.6.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \ud68c\uc0ac \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uc218\uc900 \uac1c\uc694, \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc0ac\uc6a9 \uac00\ub2a5\ud55c \uc7ac\ubb34 \uc815\ubcf4, \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Amgen Inc.<\/li>\n<li class=\"toc-level-3\">6.3.2 AstraZeneca plc<\/li>\n<li class=\"toc-level-3\">6.3.3 Bristol-Myers Squibb Co.<\/li>\n<li class=\"toc-level-3\">6.3.4 F. Hoffmann-La Roche Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.5 Incyte Corporation<\/li>\n<li class=\"toc-level-3\">6.3.6 Johnson &amp; Johnson<\/li>\n<li class=\"toc-level-3\">6.3.7 Novartis International AG<\/li>\n<li class=\"toc-level-3\">6.3.8 Pfizer Inc.<\/li>\n<li class=\"toc-level-3\">6.3.9 Sanofi S.A.<\/li>\n<li class=\"toc-level-3\">6.3.10 Teva Pharmaceutical Industries Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.11 Astellas Pharma Inc.<\/li>\n<li class=\"toc-level-3\">6.3.12 Otsuka Holdings Co., Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.13 BeiGene Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.14 Gilead Sciences, Inc. (Kite Pharma)<\/li>\n<li class=\"toc-level-3\">6.3.15 AbbVie Inc.<\/li>\n<li class=\"toc-level-3\">6.3.16 Takeda Pharmaceutical Co. Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.17 GlaxoSmithKline plc<\/li>\n<li class=\"toc-level-3\">6.3.18 Bluebird bio, Inc.<\/li>\n<li class=\"toc-level-3\">6.3.19 Jazz Pharmaceuticals plc<\/li>\n<li class=\"toc-level-3\">6.3.20 Kura Oncology, Inc.<\/li>\n<li class=\"toc-level-3\">6.3.21 Ascentage Pharma<\/li>\n<li class=\"toc-level-3\">6.3.22 Servier Pharmaceuticals<\/li>\n<li class=\"toc-level-3\">6.3.23 Bayer AG<\/li>\n<li class=\"toc-level-3\">6.3.24 Sun Pharma Industries Ltd.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ubc31\ud608\ubcd1 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8, \uc131\uc7a5, \uc810\uc720\uc728 \ubc0f \uc0b0\uc5c5 \ub3d9\ud5a5 2031<\/p>\n<p>\uc2dc\uc7a5 \uac1c\uc694<\/p>\n<p>\ubc31\ud608\ubcd1 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 2025\ub144 221\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 2026\ub144 235\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud588\uc73c\uba70, 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 6.62%\ub97c \uae30\ub85d\ud558\uba70 2031\ub144\uc5d0\ub294 324\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 FDA \uc2b9\uc778\uc744 \ubc1b\uc740 \uba54\ub2cc \uc5b5\uc81c\uc81c \ub808\ubd80\uba54\ub2d9(revumenib)\uacfc \uae30\uc874 \uce58\ub8cc\ubc95\ubcf4\ub2e4 \ub354 \uae4a\uace0 \uc9c0\uc18d\uc801\uc778 \uad00\ud574\ub97c \ubcf4\uc774\ub294 CAR-T \uc81c\ud488\uc758 \ud655\uc0b0\uc5d0 \ud798\uc785\uc740 \ubc14\uac00 \ud07d\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc9c0\ud45c (2026-2031\ub144 \uc608\uce21)<br \/>\n*   \uc5f0\uad6c \uae30\uac04: 2021\ub144 &#8211; 2031\ub144<br \/>\n*   2026\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 235\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   2031\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 324\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   \uc131\uc7a5\ub960 (2026-2031\ub144): 6.62% CAGR<br \/>\n*   \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5: \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<br \/>\n*   \uac00\uc7a5 \ud070 \uc2dc\uc7a5: \ubd81\ubbf8<br \/>\n*   \uc2dc\uc7a5 \uc9d1\uc911\ub3c4: \uc911\uac04<br \/>\n*   \uc8fc\uc694 \uae30\uc5c5: \ub178\ubc14\ud2f0\uc2a4(Novartis), \uc874\uc2a8\uc564\ub4dc\uc874\uc2a8(Johnson &#038; Johnson), \ube0c\ub9ac\uc2a4\ud1a8 \ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045(Bristol Myers Squibb) \ub4f1 (\uc21c\uc11c \ubb34\uad00)<\/p>\n<p>\uc2dc\uc7a5 \ubd84\uc11d \ubc0f \ub3d9\ud5a5<\/p>\n<p>\uc131\uc7a5 \ub3d9\ub825:<br \/>\n1.  \ubc31\ud608\ubcd1 \ubd80\ub2f4 \uc99d\uac00: \uc804 \uc138\uacc4\uc801\uc73c\ub85c \ubc31\ud608\ubcd1 \ubc1c\ubcd1\ub960\uc774 \uc9c0\uc18d\uc801\uc73c\ub85c \uc99d\uac00\ud558\uace0 \uc788\uc73c\uba70, \ud2b9\ud788 \uace0\uc18c\ub4dd \uad6d\uac00\uc758 \uace0\ub839\ud654\uc640 \uc2e0\ud765 \uacbd\uc81c\uad6d\uc758 \uc9c4\ub2e8 \uc811\uadfc\uc131 \ud5a5\uc0c1\uc774 \uc0c8\ub85c\uc6b4 \ud658\uc790 \uc720\uc785\uc744 \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \ub9cc\uc131 \uad00\ub9ac \ubc0f \uc644\uce58 \ubaa9\uc801\uc758 \uc815\ubc00 \uc758\uc57d\ud488\uc5d0 \ub300\ud55c \ud22c\uc790\ub97c \uc720\ub3c4\ud558\uc5ec \uc2dc\uc7a5 \uc218\uc694\ub97c \uacac\uace0\ud558\uac8c \ud569\ub2c8\ub2e4.<br \/>\n2.  \ud45c\uc801 \ubc0f \uba74\uc5ed \uce58\ub8cc\ubc95 \ubc1c\uc804: \ub808\ubd80\uba54\ub2d9\uacfc \uac19\uc740 \uba54\ub2cc \uc5b5\uc81c\uc81c\ub294 \uc0c8\ub85c\uc6b4 \uc57d\ubb3c \uacc4\uc5f4\uc744 \uac1c\ucc99\ud558\uace0 \uc788\uc73c\uba70, \ube14\ub9ac\ub098\ud22c\ubaa8\ub9d9(blinatumomab)\uacfc \uacb0\ud569\ub41c CAR-T \uc694\ubc95\uc740 \uc18c\uc544 \uae09\uc131 \ub9bc\ud504\uad6c\uc131 \ubc31\ud608\ubcd1\uc5d0\uc11c \ub192\uc740 \ubb34\ubcd1 \uc0dd\uc874\uc728\uc744 \ubcf4\uc774\uba70 \ud601\uc2e0\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ubc1c\uc804\uc740 \uacbd\uc7c1\uc0ac\ub4e4\uc774 \ud601\uc2e0 \uc8fc\uae30\ub97c \ub2e8\ucd95\ud558\ub3c4\ub85d \uc555\ubc15\ud558\uba70, R&#038;D \ud22c\uc790 \ubc0f \ub77c\uc774\uc120\uc2f1 \ud65c\ub3d9\uc744 \uc99d\uac00\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n3.  \uc870\uae30 \uc9c4\ub2e8 \ubc0f \ud658\uc790 \uc778\uc2dd \ud5a5\uc0c1: \uc5fc\uc0c9\uccb4 \ud504\ub85c\ud30c\uc77c\ub9c1 \ubc0f \uc561\uccb4 \uc0dd\uac80\uc774 \ubcf4\ud3b8\ud654\ub418\uace0 \uc788\uc73c\uba70, \uc720\uc804\uc790 \uc2a4\ud06c\ub9ac\ub2dd \ud504\ub85c\uadf8\ub7a8\uc740 \ucd5c\uc801\uc758 \uce58\ub8cc\ubc95 \uc120\ud0dd\uc744 \uac00\uc18d\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc870\uae30 \uac1c\uc785\uc740 \uc785\uc6d0 \ube44\uc6a9\uc744 \uc808\uac10\ud558\uace0 \uc804\ubc18\uc801\uc778 \uc0dd\uc874\uc728\uc744 \ud5a5\uc0c1\uc2dc\ucf1c \uace0\uac00 \uc815\ubc00 \uc758\uc57d\ud488\uc5d0 \ub300\ud55c \ubcf4\ud5d8\uc0ac\uc758 \uc9c0\ubd88 \uc758\uc9c0\ub97c \uac15\ud654\ud569\ub2c8\ub2e4.<br \/>\n4.  \uc804\ub7b5\uc801 \ud611\ub825 \ubc0f R&#038;D \ud22c\uc790: \ud30c\uc774\ud504\ub77c\uc778\uc758 \ubcf5\uc7a1\uc131\uc73c\ub85c \uc778\ud574 \uae30\uc5c5\ub4e4\uc740 \uc790\uc0b0 \uacf5\ub3d9 \uac1c\ubc1c \ubc0f \uc81c\uc870 \uc804\ubb38 \uc9c0\uc2dd \uacf5\uc720\ub97c \ucd94\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc544\uc2a4\ud2b8\ub77c\uc81c\ub124\uce74(AstraZeneca)\uc758 \uc140\ub809\ud2f0\uc2a4(Cellectis) \ud22c\uc790, \ucfe0\ub77c \uc628\ucf5c\ub85c\uc9c0(Kura Oncology)\uc640 \ucfc4\uc640 \uae30\ub9b0(Kyowa Kirin)\uc758 \uc81c\ud734 \ub4f1\uc774 \ub300\ud45c\uc801\uc778 \uc608\ub85c, \uc774\ub294 \ud6c4\uae30 \ub2e8\uacc4 \ud504\ub85c\uadf8\ub7a8\uc758 \uc704\ud5d8\uc744 \uc904\uc774\uace0 \uc784\uc0c1 \uc2dc\ud5d8 \uc2e4\ud589\uc744 \uac00\uc18d\ud654\ud558\uc5ec \uc2dc\uc7a5\uc744 \ud655\ub300\ud569\ub2c8\ub2e4.<br \/>\n5.  \uc870\ud569 \uce58\ub8cc \uc694\ubc95 \ucc44\ud0dd: \ub2e4\uc591\ud55c \uce58\ub8cc\ubc95\uc744 \ubcd1\uc6a9\ud558\ub294 \uc694\ubc95\uc758 \ucc44\ud0dd\uc774 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n6.  AI \uae30\ubc18 \uc57d\ubb3c \uc7ac\ucc3d\ucd9c: AI \uae30\ubc18 \uc57d\ubb3c \uc7ac\ucc3d\ucd9c\uc740 \uc2e0\uc57d \uac1c\ubc1c \ud30c\uc774\ud504\ub77c\uc778\uc744 \uac00\uc18d\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc81c\uc57d \uc694\uc778:<br \/>\n1.  \uc2e0\uaddc \uce58\ub8cc\uc81c\uc758 \ub192\uc740 \ube44\uc6a9: \uc790\uac00 CAR-T \uce58\ub8cc\uc81c\ub294 \ubbf8\uad6d\uc5d0\uc11c 30\ub9cc~60\ub9cc \ub2ec\ub7ec\uc5d0 \ub2ec\ud558\uc5ec \ubcf4\ud5d8 \uc7ac\uc815\uc5d0 \uc0c1\ub2f9\ud55c \ubd80\ub2f4\uc744 \uc8fc\uace0 \uc800\uc18c\ub4dd \uc9c0\uc5ed\uc5d0\uc11c\uc758 \ucc44\ud0dd\uc744 \uc81c\ud55c\ud569\ub2c8\ub2e4. \uc778\ub3c4 \uc81c\uc870\uc5c5\uccb4\ub4e4\uc774 \ud604\uc9c0 \uc0dd\uc0b0\uc744 \ud1b5\ud574 \uac00\uaca9\uc744 3\ub9cc~5\ub9cc \ub2ec\ub7ec\ub85c \ub0ae\ucd94\uace0 \uc788\uc9c0\ub9cc, \uc804 \uc138\uacc4\uc801\uc778 \uac00\uaca9 \ud3c9\uac00\ub294 \uc5ec\uc804\ud788 \uc694\uc6d0\ud569\ub2c8\ub2e4.<br \/>\n2.  \uc5c4\uaca9\ud55c \uaddc\uc81c \ubc0f \uc0c1\ud658 \uc7a5\ubcbd: \uc2e0\uaddc \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c \uc5c4\uaca9\ud55c \uaddc\uc81c \uc2b9\uc778 \uc808\ucc28\uc640 \uc0c1\ud658 \uc815\ucc45\uc740 \uc2dc\uc7a5 \uc9c4\uc785\uacfc \ud655\uc0b0\uc744 \uc9c0\uc5f0\uc2dc\ud0a4\ub294 \uc694\uc778\uc785\ub2c8\ub2e4.<br \/>\n3.  \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \ubc0f \uc138\ud3ec \uce58\ub8cc\uc81c \uc81c\uc870 \ubcd1\ubaa9 \ud604\uc0c1: CAR-T \uc0dd\uc0b0 \ub77c\uc778\uc744 \uc720\uc9c0\ud558\ub294 \ud559\uc220 \uc13c\ud130\ub294 63%\uc5d0 \ubd88\uacfc\ud558\uba70, 3~5\uc8fc\uc758 \uc81c\uc870 \uae30\uac04\uc740 \ube44\uc6a9\uc744 \uc99d\uac00\uc2dc\ud0a4\uace0 \uc784\uc0c1 \uacb0\uacfc\ub97c \uc800\ud574\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. GMP \ub4f1\uae09 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130\uc758 \ubd80\uc871 \ub610\ud55c \uc9c0\uc5f0\uc744 \ucd08\ub798\ud558\uc5ec \uc2e4\uc81c \uce58\ub8cc\ub7c9\uacfc \uc131\uc7a5\uc744 \uc81c\ud55c\ud569\ub2c8\ub2e4.<br \/>\n4.  \ucf5c\ub4dc\uccb4\uc778 \ubb3c\ub958\uc758 \ud55c\uacc4: \uc800\uc18c\ub4dd \ubc0f \uc911\uac04 \uc18c\ub4dd \uad6d\uac00(LMICs)\uc758 \ucf5c\ub4dc\uccb4\uc778 \ubb3c\ub958 \uc778\ud504\ub77c \ubd80\uc871\uc740 \uce58\ub8cc\uc81c \uc811\uadfc\uc131\uc744 \uc81c\ud55c\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p>1.  \uce58\ub8cc \uc720\ud615\ubcc4:<br \/>\n    *   \ud45c\uc801 \uce58\ub8cc: 2025\ub144 \ubc31\ud608\ubcd1 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 33.20%\ub97c \ucc28\uc9c0\ud558\uba70, BTK \ubc0f \uba54\ub2cc \uc5b5\uc81c\uc81c\uac00 \uc8fc\ub3c4\ud569\ub2c8\ub2e4.<br \/>\n    *   CAR-T \uc138\ud3ec \uce58\ub8cc: 2031\ub144\uae4c\uc9c0 16.35%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc801\uc751\uc99d \ud655\ub300 \ubc0f \uc548\uc804\uc131 \uad00\ub9ac \uac1c\uc120\uc5d0 \ud798\uc785\uc5b4 \uad11\ubc94\uc704\ud55c \ud654\ud559\uc694\ubc95\uc5d0\uc11c \ubc97\uc5b4\ub098 CAR-T\uc640 \uc774\uc911\ud2b9\uc774\ud56d\uccb4 \ub610\ub294 \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c\ub97c \ud63c\ud569\ud558\ub294 \ubcd1\uc6a9 \uc784\uc0c1 \uc2dc\ud5d8\uc758 \uae30\ubc18\uc744 \ub9c8\ub828\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n    *   \uc904\uae30\uc138\ud3ec \uc774\uc2dd: \ud2b8\ub808\uc624\uc124\ud310-\ud50c\ub8e8\ub2e4\ub77c\ube48(treosulfan-fludarabine) \ubcd1\uc6a9 \uc694\ubc95\uc758 FDA \uc2b9\uc778\uacfc \uac19\uc740 \ucee8\ub514\uc154\ub2dd \uc694\ubc95\uc758 \ubc1c\uc804\uc774 \uc774\uc2dd\uc758 \ud6a8\uacfc\ub97c \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>2.  \ubc31\ud608\ubcd1 \uc720\ud615\ubcc4:<br \/>\n    *   \ub9cc\uc131 \ub9bc\ud504\uad6c\uc131 \ubc31\ud608\ubcd1(CLL): 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728 24.20%\ub85c \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud558\uba70, BTK \uc5b5\uc81c\uc81c \ubc0f \ubca0\ub124\ud1a0\ud074\ub77d\uc2a4(venetoclax) \ubcd1\uc6a9 \uc694\ubc95\uc758 \ubc18\ubcf5\uc801\uc778 \ucd9c\uc2dc\uac00 \uc131\uc7a5\uc744 \uacac\uc778\ud569\ub2c8\ub2e4.<br \/>\n    *   \uae09\uc131 \ub9bc\ud504\uad6c\uc131 \ubc31\ud608\ubcd1(ALL): 10.05%\uc758 CAGR\ub85c \ube60\ub974\uac8c \uc131\uc7a5\ud558\uba70, \uc18c\uc544\uc5d0\uc11c\uc758 \uc131\uacf5\uacfc \uc131\uc778 CAR-T \uc801\uc751\uc99d \ud655\ub300\uac00 \uc8fc\uc694 \ub3d9\ub825\uc785\ub2c8\ub2e4.<br \/>\n    *   \uae09\uc131 \uace8\uc218\uc131 \ubc31\ud608\ubcd1(AML): \uba54\ub2cc \uc5b5\uc81c\uc81c \ubc0f \ubca0\ub124\ud1a0\ud074\ub77d\uc2a4 \uae30\ubc18 \uc0bc\uc911 \uc694\ubc95\uc5d0 \uc758\ud574 \uc131\uc7a5\uc774 \ucd09\uc9c4\ub429\ub2c8\ub2e4.<br \/>\n    *   \ub9cc\uc131 \uace8\uc218\uc131 \ubc31\ud608\ubcd1(CML): \ub178\ubc14\ud2f0\uc2a4\uc758 \uc2a4\ucf10\ube14\ub9ad\uc2a4(Scemblix)\uc640 \uac19\uc740 \uc2e0\uc57d\uc774 \ud45c\uc900 \ud2f0\ub85c\uc2e0 \ud0a4\ub098\uc544\uc81c \uc5b5\uc81c\uc81c\ubcf4\ub2e4 \uc6b0\uc218\ud55c \ubd84\uc790 \ubc18\uc751\uc744 \uc81c\uacf5\ud558\uba70 \uc131\uc7a5\uc5d0 \uae30\uc5ec\ud569\ub2c8\ub2e4.<br \/>\n    *   \ubd84\uc790 \uc544\ud615 \ubd84\ub958: NPM1 \ubcc0\uc774 \ubc0f KMT2A \uc7ac\ubc30\uc5f4 \ubc31\ud608\ubcd1\uacfc \uac19\uc740 \ubd84\uc790 \uc544\ud615 \ubd84\ub958\ub294 \ub9de\ucda4\ud615 \uce58\ub8cc\uc81c \uac1c\ubc1c\uc744 \ucd09\uc9c4\ud558\uc5ec \uc2dc\uc7a5\uc744 \uc138\ubd84\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>3.  \uce58\ub8cc \uc591\uc2dd\ubcc4:<br \/>\n    *   \uc800\ubd84\uc790 \uc57d\ubb3c: 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728 34.00%\ub97c \ucc28\uc9c0\ud558\uba70, \uacbd\uad6c\uc6a9 BTK, BCL-2, FLT3 \uc5b5\uc81c\uc81c\uac00 \uac15\uc138\ub97c \ubcf4\uc785\ub2c8\ub2e4.<br \/>\n    *   \uc720\uc804\uc790 \uce58\ub8cc: CRISPR \ud3b8\uc9d1 \ub3d9\uc885 CAR-T \ubc0f \ubc14\uc774\ub7ec\uc2a4 \uc5c6\ub294 \uc0dd\uccb4 \ub0b4 \uc720\uc804\uc790 \ud3b8\uc9d1\uacfc \uac19\uc740 \uc720\uc804\uc790 \uce58\ub8cc\ubc95\uc740 2031\ub144\uae4c\uc9c0 11.05%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ub3d9\uc885 \uc811\uadfc\ubc95\uc740 \uc81c\uc870 \uc2dc\uac04\uc744 \ub2e8\ucd95\ud558\uace0 \ud658\uc790 \uc801\uaca9\uc131\uc744 \ud655\ub300\ud558\uc5ec \uc790\uac00 \uce58\ub8cc\uc758 \uc81c\uc57d\uc744 \uc644\ud654\ud569\ub2c8\ub2e4.<\/p>\n<p>4.  \ud22c\uc5ec \uacbd\ub85c\ubcc4:<br \/>\n    *   \uacbd\uad6c \uc81c\ud615: 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728 45.90%\ub97c \ucc28\uc9c0\ud588\uc73c\ub098, \uc8fc\uc785 \uae30\ubc18 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uac00 \uc18d\ub3c4\ub97c \ub0b4\uba74\uc11c \uc0c1\ub300\uc801\uc73c\ub85c \uac10\uc18c\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n    *   \uc815\ub9e5 \uc8fc\uc0ac: CAR-T, \ub2e8\uc77c\ud074\ub860 \ubc0f \uc774\uc911\ud2b9\uc774\ud56d\uccb4 \uc8fc\uc785\uacfc \uc5f0\uacc4\ub418\uc5b4 11.20%\uc758 CAGR\ub85c \uc99d\uac00\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \ud53c\ud558 \uc8fc\uc0ac\ud615 \ub2e8\uc77c\ud074\ub860 \ud56d\uccb4\ub294 \uc678\ub798 \ud658\uc790 \ud3b8\uc758\uc131\uc744 \uc81c\uacf5\ud558\uc5ec \uc815\ub9e5 \uc8fc\uc0ac \uc131\uc7a5\uc744 \uc644\ud654\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>5.  \uc5f0\ub839 \uadf8\ub8f9\ubcc4:<br \/>\n    *   \uc131\uc778 \ud658\uc790: 2025\ub144 \ubc31\ud608\ubcd1 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 64.80%\ub97c \ucc28\uc9c0\ud558\uba70, \uace0\ub839 \ud658\uc790\uc5d0\uc11c CLL \ubc0f AML \ubc1c\ubcd1\ub960\uc774 \ub192\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4.<br \/>\n    *   \uc18c\uc544 \ud658\uc790: \ud604\uc7ac 35.20%\ub97c \ucc28\uc9c0\ud558\uba70 \uc5f0\uac04 9.78%\uc758 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc18c\uc544 ALL\uc5d0\uc11c CAR-T\uc640 \ube14\ub9ac\ub098\ud22c\ubaa8\ub9d9 \ubcd1\uc6a9 \uc694\ubc95\uc774 96%\uc758 \ubb34\ubcd1 \uc0dd\uc874\uc728\uc744 \ub2ec\uc131\ud558\ub294 \ub4f1 \ud601\uc2e0\uc774 \uc9d1\uc911\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>1.  \ubd81\ubbf8: 2025\ub144 \uc804 \uc138\uacc4 \ub9e4\ucd9c\uc758 43.10%\ub97c \ucc28\uc9c0\ud558\uba70 \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc785\ub2c8\ub2e4. \uc870\uae30 \ucc44\ud0dd, \uad11\ubc94\uc704\ud55c \ubcf4\ud5d8 \uc801\uc6a9, \uacac\uace0\ud55c \uc784\uc0c1 \uc778\ud504\ub77c, \uc2e0\uc18d \uc2b9\uc778 \uc808\ucc28\uac00 \uc131\uc7a5\uc744 \uacac\uc778\ud569\ub2c8\ub2e4. CAR-T \ubc0f \uc720\uc804\uc790 \ud3b8\uc9d1 \uc194\ub8e8\uc158\uc758 \uc120\ub450 \uc8fc\uc790\ub85c\uc11c \uc2dc\uc7a5 \ub9ac\ub354\uc2ed\uc744 \uc720\uc9c0\ud560 \uac83\uc785\ub2c8\ub2e4.<br \/>\n2.  \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591: 2031\ub144\uae4c\uc9c0 9.20%\uc758 \uac00\uc7a5 \ub192\uc740 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc778\ub3c4\uc758 \uc800\ub834\ud55c CAR-T \uce58\ub8cc\uc81c, \uc77c\ubcf8\uc758 \uc5d0\uc790\ub974\ubbf8\uc544(Ezharmia) \ubc0f \uc544\uce7c\ub77c\ube0c\ub8e8\ud2f0\ub2d9(acalabrutinib) \uc2b9\uc778, \uc911\uad6d\uc758 \uc0dd\uc874\uc728 \uac1c\uc120 \ub4f1\uc774 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4. \ud604\uc9c0 \uc81c\uc870 \ud5c8\ube0c\uc640 \uc815\ubd80 \uc9c0\uc6d0 \uc0c1\ud658 \ud504\ub85c\uadf8\ub7a8\uc774 \uc811\uadfc\uc131 \uaca9\ucc28\ub97c \uc904\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n3.  \uc720\ub7fd: EMA\uc758 \uc870\ud654\ub41c \uac80\ud1a0 \uc77c\uc815\uacfc \ubc94\uc9c0\uc5ed\uc801 \uc870\uae30 \uc811\uadfc \ud504\ub85c\uadf8\ub7a8\uc5d0 \ud798\uc785\uc5b4 \uafb8\uc900\ud55c \ud55c \uc790\ub9bf\uc218 \uc131\uc7a5\uc744 \ubcf4\uc785\ub2c8\ub2e4.<br \/>\n4.  \ub0a8\ubbf8, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74: \uc790\uc6d0 \uc81c\uc57d \ubc0f \ucf5c\ub4dc\uccb4\uc778 \ubb38\uc81c\ub85c \uc778\ud574 \ub4a4\ucc98\uc9c0\uace0 \uc788\uc9c0\ub9cc, \ubaa8\ub4c8\ud615 \ud604\uc7a5 \uc0dd\uc0b0 \uc7a5\uce58 \ubc0f \uc628\ub3c4 \uc548\uc815\uc131 \uc81c\ud615\uc774 \ud5a5\ud6c4 10\ub144\uac04 \uc7a0\uc7ac\uc801 \uc218\uc694\ub97c \ucc3d\ucd9c\ud560 \uac83\uc73c\ub85c \uae30\ub300\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\ubc31\ud608\ubcd1 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc785\ub2c8\ub2e4. \ub178\ubc14\ud2f0\uc2a4, \uc874\uc2a8\uc564\ub4dc\uc874\uc2a8, \ube0c\ub9ac\uc2a4\ud1a8 \ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045\uc774 \uad11\ubc94\uc704\ud55c \ud3ec\ud2b8\ud3f4\ub9ac\uc624\uc640 \uae00\ub85c\ubc8c \ub124\ud2b8\uc6cc\ud06c\ub97c \ud65c\uc6a9\ud558\uc5ec \uc57d 35%\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc2e0\ub2e5\uc2a4 \ud30c\ub9c8\uc288\ud2f0\uceec\uc2a4(Syndax Pharmaceuticals)\uc640 \uac19\uc740 \uc18c\uaddc\ubaa8 \ud601\uc2e0 \uae30\uc5c5\ub4e4\uc740 \uc720\uc804\uc801\uc73c\ub85c \uc815\uc758\ub41c \ud558\uc704 \uc138\uadf8\uba3c\ud2b8\ub97c \ubaa9\ud45c\ub85c \ud558\ub294 \uc804\ub7b5\uc744 \ud1b5\ud574 \ud30c\uad34\uc801\uc778 \uc7a0\uc7ac\ub825\uc744 \ubcf4\uc5ec\uc8fc\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc804\ub7b5\uc801 \ud30c\ud2b8\ub108\uc2ed\uc774 \uc790\ubcf8 \ud22c\uc785\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc73c\uba70, \uc544\uc2a4\ud2b8\ub77c\uc81c\ub124\uce74\uc758 \uc140\ub809\ud2f0\uc2a4 \uc9c0\ubd84 \uc778\uc218\ub294 CRISPR \ud3b8\uc9d1 \ub3d9\uc885 CAR-T \uc5ed\ub7c9\uc744 \ud655\ubcf4\ud558\uace0, \ucfc4\uc640 \uae30\ub9b0\uacfc \ucfe0\ub77c \uc628\ucf5c\ub85c\uc9c0\uc758 \uc81c\ud734\ub294 \uba54\ub2cc \uc5b5\uc81c\uc81c\uc758 \uae00\ub85c\ubc8c \uc0c1\uc5c5\ud654\ub97c \uac00\uc18d\ud654\ud569\ub2c8\ub2e4. \uc81c\uc870 \ud601\uc2e0\uc740 \ud575\uc2ec\uc801\uc778 \ucc28\ubcc4\ud654 \uc694\uc18c\ub85c, \uae30\uc131\ud488 CAR-T \ubc0f \ud604\uc7a5 \uce58\ub8cc \ubca1\ud130\ub97c \uac1c\uc120\ud558\ub824\ub294 \uae30\uc5c5\ub4e4\uc740 \uc0dd\uc0b0 \ubcd1\ubaa9 \ud604\uc0c1\uc744 \uadf9\ubcf5\ud558\uae30 \uc704\ud574 \uacbd\uc7c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \uc804\ub7b5\uc740 AI \uae30\ubc18 \ud45c\uc801 \uc2dd\ubcc4 \ubc0f \ud1b5\ud569 \uc9c4\ub2e8 \uc11c\ube44\uc2a4\uc640 \uc810\ucc28 \uacb0\ud569\ub418\uc5b4, \uce58\ub8cc\ubc95 \uc120\ud0dd\uc744 \uc6d0\ud65c\ud55c \ud658\uc790 \uc5ec\uc815\uc5d0 \ud1b5\ud569\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc9c4\ub2e8 \ud0a4\ud2b8\uc640 \ub9de\ucda4\ud615 \uce58\ub8cc\uc81c\ub97c \ud568\uaed8 \uc81c\uacf5\ud558\ub294 \uae30\uc5c5\ub4e4\uc740 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc0b0\uc5c5 \ubc1c\uc804<br \/>\n*   2025\ub144 6\uc6d4: \uc874\uc2a8\uc564\ub4dc\uc874\uc2a8\uc740 KMT2A \ubc0f NPM1 \ubcc0\uc774 AML \ud658\uc790\ub97c \ub300\uc0c1\uc73c\ub85c \ube14\ub809\uc2dc\uba54\ub2d9(bleximenib)\uacfc \ubca0\ub124\ud1a0\ud074\ub77d\uc2a4 \ubc0f \uc544\uc790\uc2dc\ud2f0\ub518(azacitidine) \ubcd1\uc6a9 \uc694\ubc95\uc758 \uae0d\uc815\uc801\uc778 1b\uc0c1 \ub370\uc774\ud130\ub97c \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 3\uc6d4: \uc140\ub85c\uc820 \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Cellogen Therapeutics)\ub294 \ud608\uc561\uc554\uc744 \ud45c\uc801\ud558\ub294 \uc774\uc911\ud2b9\uc774\uc131 3\uc138\ub300 CAR-T \ud50c\ub7ab\ud3fc\uc5d0 \ub300\ud55c \uc778\ub3c4 \ud2b9\ud5c8\ub97c \ud68d\ub4dd\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 1\uc6d4: FDA\ub294 AML \ubc0f \uace8\uc218\uc774\ud615\uc131\uc99d\ud6c4\uad70 \ud658\uc790\uc758 \ub3d9\uc885 \uc904\uae30\uc138\ud3ec \uc774\uc2dd\uc744 \uc704\ud55c \ud2b8\ub808\uc624\uc124\ud310-\ud50c\ub8e8\ub2e4\ub77c\ube48 \ucee8\ub514\uc154\ub2dd \uc694\ubc95\uc744 \uc2b9\uc778\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 11\uc6d4: \uc2e0\ub2e5\uc2a4 \ud30c\ub9c8\uc288\ud2f0\uceec\uc2a4\ub294 KMT2A \uc7ac\ubc30\uc5f4 \uae09\uc131 \ubc31\ud608\ubcd1 \ud658\uc790\ub97c \uc704\ud55c \ucd5c\ucd08\uc758 \uba54\ub2cc \uc5b5\uc81c\uc81c\uc778 \ub808\ubd80\ud3ec\ub974\uc9c0(Revuforj, revumenib)\uc5d0 \ub300\ud574 FDA \uc2b9\uc778\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \uc804 \uc138\uacc4 \ubc31\ud608\ubcd1 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc5d0 \ub300\ud55c \uc2ec\uce35 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc5f0\uad6c \ubc94\uc704\ub294 \ubaa8\ub4e0 \uc5f0\ub839\ub300 \ubc0f \uce58\ub8cc \ub2e8\uacc4\uc5d0\uc11c \uae09\uc131 \ubc0f \ub9cc\uc131 \ubc31\ud608\ubcd1 \uce58\ub8cc\uc5d0 \uc0ac\uc6a9\ub418\ub294 \ubaa8\ub4e0 \ube0c\ub79c\ub4dc \ubc0f \uc81c\ub124\ub9ad \uc57d\ubb3c, \uc18c\ubd84\uc790 \uc57d\ubb3c, \ub2e8\uc77c\ud074\ub860 \ud56d\uccb4, \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4, \ud2f0\ub85c\uc2e0 \ud0a4\ub098\uc544\uc81c \uc5b5\uc81c\uc81c, CAR-T \ubc0f \uae30\ud0c0 \uc138\ud3ec \uae30\ubc18 \uba74\uc5ed \uc694\ubc95\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4. \ubcd1\uc6d0, \uc804\ubb38 \ud074\ub9ac\ub2c9, \uc18c\ub9e4 \ucc44\ub110\uc744 \ud1b5\ud55c \uc81c\ud488 \ud310\ub9e4\uac00 \ubaa8\ub450 \ud3ec\ud568\ub429\ub2c8\ub2e4. \ub2e4\ub9cc, \uc9c4\ub2e8 \uac80\uc0ac \ube44\uc6a9, \uc218\ud608 \uc9c0\uc6d0, \ud56d\uac10\uc5fc \uc608\ubc29, \uc904\uae30\uc138\ud3ec \uc774\uc2dd \uc11c\ube44\uc2a4\ub294 \uc5f0\uad6c \ubc94\uc704\uc5d0\uc11c \uc81c\uc678\ub429\ub2c8\ub2e4.<\/p>\n<p>\ubcf4\uace0\uc11c\ub294 \uc2dc\uc7a5\uc758 \uc8fc\uc694 \ub3d9\uc778\uacfc \uc81c\uc57d \uc694\uc778\uc744 \ubd84\uc11d\ud558\uace0, \uce58\ub8cc \uc720\ud615, \ubc31\ud608\ubcd1 \uc720\ud615, \uce58\ub8cc \uc591\uc2dd, \ud22c\uc5ec \uacbd\ub85c, \uc5f0\ub839\ub300 \ubc0f \uc9c0\uc5ed\ubcc4\ub85c \uc2dc\uc7a5 \uaddc\ubaa8\uc640 \uc131\uc7a5 \uc608\uce21\uc744 \uc81c\uc2dc\ud569\ub2c8\ub2e4. \ub610\ud55c \uacbd\uc7c1 \ud658\uacbd\uacfc \ubbf8\ub798 \uc2dc\uc7a5 \uae30\ud68c\ub97c \uc870\uba85\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \ub3d9\uc778: \ubc31\ud608\ubcd1 \uc720\ubcd1\ub960 \uc99d\uac00, \ud45c\uc801 \ubc0f \uba74\uc5ed \uce58\ub8cc\ubc95\uc758 \ubc1c\uc804, \uc870\uae30 \uc9c4\ub2e8 \ubc0f \ud658\uc790 \uc778\uc2dd \ud5a5\uc0c1, \uc804\ub7b5\uc801 \ud611\ub825 \ubc0f R&#038;D \ud22c\uc790 \ud655\ub300, \ubcd1\uc6a9 \uc694\ubc95 \ucc44\ud0dd \uc99d\uac00, AI \uae30\ubc18 \uc57d\ubb3c \uc7ac\ucc3d\ucd9c\uc744 \ud1b5\ud55c \ud30c\uc774\ud504\ub77c\uc778 \uac00\uc18d\ud654 \ub4f1\uc774 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778: \uc2e0\uaddc \uce58\ub8cc\uc81c\uc758 \ub192\uc740 \ube44\uc6a9, \uc5c4\uaca9\ud55c \uaddc\uc81c \ubc0f \ubcf4\ud5d8 \uc0c1\ud658 \uc7a5\ubcbd, \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \ubc0f \uc138\ud3ec \uce58\ub8cc\uc81c\uc758 \uc81c\uc870 \ubcd1\ubaa9 \ud604\uc0c1, \uc800\uc18c\ub4dd \ubc0f \uc911\uac04 \uc18c\ub4dd \uad6d\uac00(LMICs)\uc5d0\uc11c\uc758 \ucf5c\ub4dc\uccb4\uc778 \ubb3c\ub958 \ud55c\uacc4 \ub4f1\uc774 \uc2dc\uc7a5 \ud655\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc18c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc774 \uc678\uc5d0\ub3c4 \uac00\uce58\/\uacf5\uae09\ub9dd \ubd84\uc11d, \uaddc\uc81c \ud658\uacbd, \uae30\uc220 \uc804\ub9dd, \uadf8\ub9ac\uace0 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d(\uacf5\uae09\uc790 \ubc0f \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825, \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611, \ub300\uccb4\uc7ac\uc758 \uc704\ud611, \uacbd\uc7c1 \uac15\ub3c4)\uc744 \ud1b5\ud574 \uc2dc\uc7a5 \uc5ed\ud559\uc744 \ub2e4\uac01\uc801\uc73c\ub85c \ud3c9\uac00\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21:<br \/>\n\uc2dc\uc7a5\uc740 \ub2e4\uc74c \uae30\uc900\uc5d0 \ub530\ub77c \uc138\ubd84\ud654\ub418\uc5b4 \ubd84\uc11d\ub429\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc \uc720\ud615\ubcc4: \ud654\ud559 \uc694\ubc95, \uba74\uc5ed \uc694\ubc95, \ud45c\uc801 \uc694\ubc95, CAR-T \uc138\ud3ec \uc694\ubc95, \uc720\uc804\uc790 \uc694\ubc95, \uc904\uae30\uc138\ud3ec \uc774\uc2dd \ubc0f \uae30\ud0c0 \uce58\ub8cc \uc720\ud615.<br \/>\n*   \ubc31\ud608\ubcd1 \uc720\ud615\ubcc4: \uae09\uc131 \ub9bc\ud504\uad6c\uc131 \ubc31\ud608\ubcd1, \uae09\uc131 \uace8\uc218\uc131 \ubc31\ud608\ubcd1, \ub9cc\uc131 \ub9bc\ud504\uad6c\uc131 \ubc31\ud608\ubcd1, \ub9cc\uc131 \uace8\uc218\uc131 \ubc31\ud608\ubcd1 \ubc0f \uae30\ud0c0 \ubc31\ud608\ubcd1 \uc720\ud615.<br \/>\n*   \uce58\ub8cc \uc591\uc2dd\ubcc4: \uc18c\ubd84\uc790 \uc57d\ubb3c, \ub2e8\uc77c\ud074\ub860 \ud56d\uccb4, CAR-T \uc138\ud3ec \uce58\ub8cc\uc81c, \uc720\uc804\uc790 \uce58\ub8cc\uc81c, \uc774\uc911\ud2b9\uc774\uc131 \ud56d\uccb4, RNA \uae30\ubc18 \uce58\ub8cc\uc81c \ubc0f \uae30\ud0c0 \uc591\uc2dd.<br \/>\n*   \ud22c\uc5ec \uacbd\ub85c\ubcc4: \uacbd\uad6c, \uc815\ub9e5 \uc8fc\uc0ac, \ud53c\ud558 \uc8fc\uc0ac \ubc0f \uae30\ud0c0 \uacbd\ub85c.<br \/>\n*   \uc5f0\ub839\ub300\ubcc4: \uc18c\uc544(14\uc138 \ubbf8\ub9cc), \uc131\uc778(15-64\uc138), \ub178\uc778(65\uc138 \uc774\uc0c1).<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8(\ubbf8\uad6d, \uce90\ub098\ub2e4, \uba55\uc2dc\ucf54), \uc720\ub7fd(\ub3c5\uc77c, \uc601\uad6d, \ud504\ub791\uc2a4, \uc774\ud0c8\ub9ac\uc544, \uc2a4\ud398\uc778 \ubc0f \uae30\ud0c0 \uc720\ub7fd \uad6d\uac00), \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591(\uc911\uad6d, \uc77c\ubcf8, \uc778\ub3c4, \ud638\uc8fc, \ub300\ud55c\ubbfc\uad6d \ubc0f \uae30\ud0c0 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uad6d\uac00), \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74(GCC \uad6d\uac00, \ub0a8\uc544\ud504\ub9ac\uce74 \ubc0f \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74 \uad6d\uac00), \ub0a8\ubbf8(\ube0c\ub77c\uc9c8, \uc544\ub974\ud5e8\ud2f0\ub098 \ubc0f \uae30\ud0c0 \ub0a8\ubbf8 \uad6d\uac00).<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd: \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\uc640 \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ubd84\uc11d\ud558\uba70, Amgen Inc., AstraZeneca plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Johnson &#038; Johnson, Novartis International AG, Pfizer Inc. \ub4f1 20\uac1c \uc774\uc0c1\uc758 \uc8fc\uc694 \uae30\uc5c5 \ud504\ub85c\ud544\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uac01 \ud504\ub85c\ud544\uc5d0\ub294 \uae00\ub85c\ubc8c \ubc0f \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \uc0ac\ud56d\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd: \ubcf4\uace0\uc11c\ub294 \ubbf8\uac1c\ucc99 \uc2dc\uc7a5(White-Space) \ubc0f \ubbf8\ucda9\uc871 \uc218\uc694(Unmet-Need) \ud3c9\uac00\ub97c \ud1b5\ud574 \ud5a5\ud6c4 \uc2dc\uc7a5 \uae30\ud68c\uc640 \uc804\ub9dd\uc744 \uc81c\uc2dc\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-28305","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/28305"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=28305"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/28305\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=28305"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=28305"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=28305"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}